SocialPicks Sentiment:
** v.s.
other stocks
|
This Quarter's Sentiment:
|
|
|
NABI Analysis & Videos »
NABI: Bull or Bear?
Shorts will be squeezed?
NABI
|
|
|
+33.51%
in
824 days
<> Nabi is a heavily shorted stock, which has a short ratio of 21 and 14% of the float shorted. Nabi makes and sells products to help with transplantation, infectious disease, nicotine addiction and hematology. The stock has negative earnings and a P/S of 2. The stock happens to be owned by the Los Angeles-based activist hedge fund, Chapman Capital , run by Bob Chapman. His hedge fund, which he ran on the side for a couple years, had a net return of 55% in 2004 and 61.9% in 2005. Nabi is also owned by Third Point LLC , another activist hedge fund founded by Daniel Loeb. The fun...
|
The Activist Haven
NABI
|
|
|
-24.16%
in
66 days
(closed on 08/26/07)
Nabi Biopharmaceuticals (NDAQ:NABI) may be in for a fight after nearly 40% of its ownership base filed Schedule 13Ds with virtually identical activist platforms - the conversion of the company into a royalty trust following a special dividend financed by divisional asset sales. Chapman Capital noted today that while the company has outlined plans to this end, they have yet to actually execute their plans and unlock shareholder value.
Just how much would this deal be worth for shareholders? Well, Chapman Capital estimated in their letter to the board that the divisional asset sale ...
|
People Bullish on NABI
People Bearish on NABI
|
ROCK-STAR INVESTORS
|
|
POPULAR STOCKS
|
|
TODAY'S HEADLINES
|
|
TODAY'S TOP PICKS
|
|
|
| StreetInsider.com on NABI |
Be the first to start a discussion and earn 2 points.
More Resources
|
About Nabi Biopharmaceuticals
- Answers.com
